342 related articles for article (PubMed ID: 21494075)
1. Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.
Oh HJ; Kim TH; Sohn YW; Kim YS; Oh YR; Cho EY; Shim SY; Shin SR; Han AL; Yoon SJ; Kim HC
Korean J Hepatol; 2011 Mar; 17(1):27-36. PubMed ID: 21494075
[TBL] [Abstract][Full Text] [Related]
2. Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community-based cross-sectional study.
Chen LW; Huang MS; Shyu YC; Chien RN
Kaohsiung J Med Sci; 2021 Sep; 37(9):819-827. PubMed ID: 34002481
[TBL] [Abstract][Full Text] [Related]
3. Liver function tests as indicators of metabolic syndrome.
Lee HC
Korean J Hepatol; 2011 Mar; 17(1):9-11. PubMed ID: 21494072
[No Abstract] [Full Text] [Related]
4. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
Oh SY; Cho YK; Kang MS; Yoo TW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
Metabolism; 2006 Dec; 55(12):1604-9. PubMed ID: 17142131
[TBL] [Abstract][Full Text] [Related]
5. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
6. Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
Sogabe M; Okahisa T; Kurihara T; Takehara M; Kagemoto K; Okazaki J; Kida Y; Hirao A; Tanaka H; Tomonari T; Taniguchi T; Okamoto K; Nakasono M; Takayama T
PLoS One; 2020; 15(8):e0238388. PubMed ID: 32866186
[TBL] [Abstract][Full Text] [Related]
7. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease.
Chang Y; Ryu S; Sung E; Jang Y
Clin Chem; 2007 Apr; 53(4):686-92. PubMed ID: 17272484
[TBL] [Abstract][Full Text] [Related]
8. Serum hepatic enzyme activity and alcohol drinking status in relation to the prevalence of metabolic syndrome in the general Japanese population.
Uemura H; Katsuura-Kamano S; Yamaguchi M; Sawachika F; Arisawa K
PLoS One; 2014; 9(4):e95981. PubMed ID: 24755715
[TBL] [Abstract][Full Text] [Related]
9. [Association of abnormality of liver enzymes and metabolic syndrome in patients with nonalcoholic fatty liver disease].
Liu M; Yan HM; Gao X; Gao J
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):253-5. PubMed ID: 17425870
[TBL] [Abstract][Full Text] [Related]
10. Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample.
Flechtner-Mors M; George SN; Oeztuerk S; Haenle MM; Koenig W; Imhof A; Boehm BO; Graeter T; Mason RA; Kratzer W; Akinli AS;
BMC Res Notes; 2014 Apr; 7():207. PubMed ID: 24693952
[TBL] [Abstract][Full Text] [Related]
11. Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease.
Chen ZW; Chen LY; Dai HL; Chen JH; Fang LZ
J Zhejiang Univ Sci B; 2008 Aug; 9(8):616-22. PubMed ID: 18763311
[TBL] [Abstract][Full Text] [Related]
12. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents.
Park HS; Han JH; Choi KM; Kim SM
Am J Clin Nutr; 2005 Nov; 82(5):1046-51. PubMed ID: 16280437
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
[TBL] [Abstract][Full Text] [Related]
14. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Kim CH; Park JY; Lee KU; Kim JH; Kim HK
Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional and longitudinal association of serum alanine aminotransaminase and γ-glutamyltransferase with metabolic syndrome in middle-aged and elderly Chinese people.
Xu Y; Bi YF; Xu M; Huang Y; Lu WY; Gu YF; Ning G; Li XY
J Diabetes; 2011 Mar; 3(1):38-47. PubMed ID: 21199427
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.
Music M; Dervisevic A; Pepic E; Lepara O; Fajkic A; Ascic-Buturovic B; Tuna E
Med Arch; 2015 Aug; 69(4):251-5. PubMed ID: 26543313
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.
Cankurtaran M; Tayfur O; Yavuz BB; Geyik S; Akhan O; Arslan S
Acta Gastroenterol Belg; 2007; 70(3):253-9. PubMed ID: 18074733
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors associated with non-alcoholic fatty liver disease: a case-control study].
Caballería L; Arteaga I; Pera G; Rodríguez L; Alumà A; Auladell MA; Torán P
Med Clin (Barc); 2013 Sep; 141(6):233-9. PubMed ID: 23601740
[TBL] [Abstract][Full Text] [Related]
19. Serum gamma-glutamyl transferase activity predicts future development of metabolic syndrome defined by 2 different criteria.
Jo SK; Lee WY; Rhee EJ; Won JC; Jung CH; Park CY; Oh KW; Park SW; Kim SW
Clin Chim Acta; 2009 May; 403(1-2):234-40. PubMed ID: 19332046
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome increases with the increase in blood levels of gamma glutamyltransferase and alanine aminotransferase in Japanese men and women.
Oda E; Kawai R; Watanabe K; Sukumaran V
Intern Med; 2009; 48(16):1343-50. PubMed ID: 19687577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
